These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37354474)

  • 1. Expert Opinion by Clinicians on the Use of Insulin Therapy in People with Hepatic Impairment.
    Chawla P; Shunmugavelu M; Jaggi S; Asirvatham AJ; Basu D; Shah T; Farishta F; Das AK
    J Assoc Physicians India; 2023 Feb; 71(2):11-12. PubMed ID: 37354474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.
    Banerji MA; Baron MA; Gao L; Blonde L
    Postgrad Med; 2014 May; 126(3):111-25. PubMed ID: 24918797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
    Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
    Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower mean blood glucose during short-term intensive insulin therapy is associated with long-term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence-based recommendations for standardization.
    Liu L; Liu J; Xu L; Ke W; Wan X; Li H; He X; Wang L; Cao X; Xiao H; Li Y
    J Diabetes Investig; 2018 Jul; 9(4):908-916. PubMed ID: 29193795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus.
    Gentile S; Guarino G; Strollo F; Romano M; Genovese S; Masarone M; Ceriello A
    Diabetes Res Clin Pract; 2016 Mar; 113():179-86. PubMed ID: 26803356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of type 2 diabetes mellitus in the elderly.
    Soe K; Sacerdote A; Karam J; Bahtiyar G
    Maturitas; 2011 Oct; 70(2):151-9. PubMed ID: 21890292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method.
    Jain SM; Seshadri K; Unnikrishnan AG; Chawla M; Kalra P; Vipin VP; Ravishankar E; Chordia J; Das S; Wasir J; Bandookwala SM; Deka N; Agarwal G; Vijaykumar G; Erande S
    Diabetes Ther; 2020 Mar; 11(3):621-632. PubMed ID: 32009224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach.
    El Fathi A; Fabris C; Breton MD
    Front Endocrinol (Lausanne); 2021; 12():795895. PubMed ID: 35082757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the treatment of patients with diabetes using insulin analogues: current findings and future directions.
    Lefever E; Vliebergh J; Mathieu C
    Expert Opin Drug Saf; 2021 Feb; 20(2):155-169. PubMed ID: 33249944
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care.
    Mehta R; Goldenberg R; Katselnik D; Kuritzky L
    Ann Med; 2021 Dec; 53(1):998-1009. PubMed ID: 34165382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
    Yacoub T
    Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network meta-analysis of glucose-lowering drug treatment regimens with the potential risk of hypoglycemia in patients with type 2 diabetes mellitus in terms of glycemic control and severe hypoglycemia.
    Kodama S; Fujihara K; Ishiguro H; Matsubayashi Y; Kitazawa M; Iwanaga M; Yamada T; Kato K; Nakagawa Y; Tanaka S; Shimano H; Sone H
    J Investig Med; 2023 Apr; 71(4):400-410. PubMed ID: 36695427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.